Kensington, MD, United States of America

Mary R Flack


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1995-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mary R Flack: Innovator in Cancer Treatment

Introduction

Mary R Flack is a notable inventor based in Kensington, MD (US), recognized for her contributions to cancer treatment. With a total of 2 patents, she has made significant strides in the field of oncology through her innovative methods and pharmaceutical compositions.

Latest Patents

Flack's latest patents focus on the use of gossypol and gossypol acetic acid for treating cancer. One patent describes a method for treating cancer in humans by administering an anti-cancer effective amount of gossypol, gossypol acetic acid, gossypolone, or their physiologically acceptable salts. This method also includes the combination of these compounds with conventional chemotherapeutic agents. Another patent emphasizes the use of gossypol acetic acid alone or in combination with other chemotherapeutic agents to effectively treat cancer. Both inventions also encompass pharmaceutical compositions that combine these compounds with conventional treatments.

Career Highlights

Throughout her career, Mary R Flack has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the Secretary of Health. Her work has contributed to advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Flack has collaborated with notable professionals in her field, including Richard Knazek and Marcus Reidenberg. These partnerships have further enhanced her research and development efforts in cancer therapies.

Conclusion

Mary R Flack's innovative work in cancer treatment through her patents on gossypol and gossypol acetic acid showcases her dedication to improving healthcare. Her contributions continue to influence the field of oncology and offer hope for effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…